|Day's Range||0.065 - 0.065|
|52 Week Range||0.010 - 0.155|
|PE Ratio (TTM)||-4.64|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Calyx Bio-Ventures Inc. is pleased to announce that it has entered into a letter agreement to acquire the remaining software assets and clients related to the existing software framework purchased in November ...
This document corrects and replaces the press release that was sent today at 8:00 am ET. The embedded URL was changed.
Calyx Bio-Ventures Inc. is pleased to provide an update on its ongoing business operations and the development of its industry leading technology platform for mass communications and collaboration.